Tage Honore, Director: Vanda Pharmaceuticals VNDA Planned sale · Filed 02/23

Trade details

Type: Planned sale notice
Stock: Vanda Pharmaceuticals VNDA
Person: Tage HonoreDirector
Planned sale date: 26/02/23
Filed: 26/02/23

$240.9K to be sold

Vanda Pharmaceuticals trades, last 26 weeks

What else happened in Vanda Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 01/24~03/25

Tage Honore's recent trades

Tage HonoreDirector
SellVanda Pharmaceuticals
Sell
Vanda Pharmaceuticals
VNDA
$240.9K
30,000 sh
$240.9K
Filed 02/24
Traded 02/23